COMMITMENTS AND CONTINGENCIES (Details Textual) (USD $)	0 Months Ended	3 Months Ended		0 Months Ended	12 Months Ended
	Sep. 02, 2014	Mar. 31, 2015	Mar. 31, 2014	Jun. 10, 2013	Dec. 31, 2013	Sep. 30, 2014
COMMITMENTS AND CONTINGENCIES [Line Items]
Cost of Services		$ 1,206,312	$ 0
Research and Development Expense, Total		797,225	422,503
Amortization Of Capital Lease Equipment Straight Line Basis		5 years
Other Commitments, Description	On September 1, 2014, the NRLBH entered into a three year agreement with TME Research LLC (TME) which requires TME to provide to the NRLBH 100 tissue specimens in connection with the development of the NextCYTE test. Fees payable to TME under the agreement includes $99,600 up front, $31,500 upon supplying the first 25 specimens and $31,500 at the time of final delivery of all specimens. The agreement is terminable with 60 days prior written notice or immediately upon a material breach.
Targeted Medical Education [Member] | Master Service Agreement [Member]
COMMITMENTS AND CONTINGENCIES [Line Items]
Research and Development Expense, Total		162,600
A5 Genetics KFT [Member]
COMMITMENTS AND CONTINGENCIES [Line Items]
Cost of Services, Licenses and Services			100,000
Additional License Fee Amount Paid					100,000
Additional License Fee Obligation Amount				1,200,000
Royalty Expense				50
Cost of Services				65
Affymetrix In [Member] | OwnerChip Program Agreement [Member] | Subsidiaries [Member]
COMMITMENTS AND CONTINGENCIES [Line Items]
Payments for Software		21,590			94,723
Purchase Obligation		647,700				142,005
Contract Payable, Due in Rolling Year Two		51,600
Capital Leased Assets, Gross		206,702
NRLBH [Member]
COMMITMENTS AND CONTINGENCIES [Line Items]
Minimum Purchase Under License Agreement to Acquire Right	452,408